APPLICATION OF ANALYTIC NETWORK PROCESS: WEIGHTING OF SELECTION CRITERIA TO SELECT THE SUITABLE METHOD FOR THE PREPARATION OF NANOCRYSTALS
HTML Full TextAPPLICATION OF ANALYTIC NETWORK PROCESS: WEIGHTING OF SELECTION CRITERIA TO SELECT THE SUITABLE METHOD FOR THE PREPARATION OF NANOCRYSTALS
Venkatesh Kyavars
Department of Pharmacy, Annamalai University, Annamalai Nagar, Chidambaram - 608002, Tamil Nadu, India.
ABSTRACT: This article presents a logical technique to select the best method for the preparation of nanocrystals by implementing the analytic network process. One of the most significant decision-making tools to make excellent decisions is Analytic Network Process which includes Model construction, Paired assessments between each two clusters or node, Super matrix assessment based on outcomes from paired comparisons, and result investigation for the evaluation. So in order to avoid wrong conclusions, we use the Analytic Network Process tool because it is well organized and logical compared to other decision-making techniques. Based on the results of the overall priority analysis, the alternative M2 Sonoprecipitation method scores 0.088857, which is highest when compared to other alternatives. This study reveals that the Sonoprecipitation method is the most appropriate technique for the preparation of Nanocrystals. This paper concludes that ANP evolved by Saaty is a good decision-making device, done by using a software super decision which is very easy to make the right decision and conclusion. With the outcome of ANP method and Super decision software, the study reveals that Sonoprecipitation method is the most suitable method for the preparation of nanocrystals since it has the highest value compared to other methods. Hence to obtain reliable and efficient decisions, ANP has been employed.
Keywords: |
Analytic network process, Nanocrystals, Weighted matrix, Limit matrix, Sonoprecipitation
INTRODUCTION: Nowadays, for the treatment of a variety of diseases, technical research has been wide-spreading to determine and develop drugs. Recently it has been reported that Nano drug delivery systems like nanoparticles, nanospheres, nanosponges, solid lipid nanoparticles, molecular system (inclusion complexes), nanoemulsions, nano-vesicular system (Liposome, niosomes), nano-suspension, and Nanocrystals 1 have presented with the aim to increase bioavailability and also to optimize bioavailability by changing the concentration of drug in the body fluids 2, 3.
So in order to overcome this problem, many researchers developed an innovative drug delivery system called nanocrystals which is also a novel drug delivery system 4.
Today, Novel drug delivery systems (NDDS) are the cutting edge of research in the pharmaceutical field 5. The rate of absorption of a drug depends on the dosage form. Drugs are formulated into many dosage forms such as retarded release, sustained release, prolonged action, depot, enteric release, and timed release medication 6. The invention or discovery of so many dosage forms or medications is due to so many reasons. Some of the main reasons include viz: to reduce the production cost, expiry of the patents, lack of therapeutic efficacy and safety 7, 8.
There are a variety of approaches that are available for accomplishing NDDS such as targeted delivery systems, transdermal schemes, intravaginal and intrauterine schemes, prodrugs, ocular schemes, nanoparticles, nanocrystals, reservoir devices, injections and implants, matrix devices, and micro-encapsulation. Nanocrystals are one of the most productive advances 9.
Drug nanocrystals are nanoparticles with a crystalline character. According to the size unit, drug nanocrystals vary in size between a few to 1000 nm, and drug microcrystals possess a size of 1–1000 μm 10. Nanocrystal is composed of active pharmaceutical ingredients (API), water, and stabilizer. In order to stabilize nanocrystals, the stabilizer is added, and it depends on two mechanisms: electrostatic stabilization or steric stabilization and charge. For improved long-standing stability, occasionally, more than one stabilizer has been used 11, 12. Freeze drying is done to improve physical stability 13.
The unique features of nanocrystals include improvement of saturation solubility, dissolution velocity, and gumminess to surface/cell membranes. The most important typical features of drug nanocrystals are the increased saturation solubility and accelerated dissolution velocity 14. Another feature of drug nanocrystals is their specific adhesiveness 15. The high adhesiveness can be considered another factor in improving the oral absorption of poorly soluble drugs. The adhesive-ness of the particles to the gut wall after oral administration further enhances the bioavailability.
These nanocrystals can be applied through many administration routes, such as oral, parenteral, ocular, pulmonary, and dermal delivery. As known, the oral route is the most important and the first choice route for drug delivery because of its several advantages, including convenience, safety, inexpensive, etc. 16
There are many methods for the preparation of nanocrystals, and here, we have selected four methods: Hydrosol, Sonoprecipitation, Spray freezing into liquid, and Nanomorph®. There is a need to select a suitable method for the preparation of nanocrystals. So we have decided to use a decision-making tool such as the analytic network process to select the best method. While selecting or choosing a method or a technique to prepare nanocrystals, there are many factors that are to be taken into consideration like expenditure, consis-tency, viability, processing condition, and qualitative and quantitative analysis para-meters and then come to a conclusion when numerous options are there. The purpose of using ANP is to make or choose an optimum decision because a wrong conclusion may lead to numerous complications.
The selection of the method depends on a number of criteria and sub-criteria. The rest of this paper is about: introduction to ANP, the proposed ANP algorithm (steps), an application for appropriate preparation method assortment utilizing ANP. The last part concludes the outcome 9.
Analytic Network Process: The Analytic Network Process (ANP) is a multi-criteria decision-making tool is introduced by Saaty 9. This is a significant decision-making tool to make excellent decision 17. Multi-Criteria Decision Making (MCDM) means choosing or prioritizing alternatives from a set of accessible alternatives with respect to multiple criteria 9. In both AHP and ANP decision problem is structured hierarchically from an overall objective at the top to various criteria, sub-criteria, and so on until decision alternatives at the lowest level 9. Decision-makers have to judge each element, and the judgments are made on the basis of decision-makers' experience and knowledge.
One of the most significant decisions supporting tool is the Analytic Network Process which is the generalization of Saaty’s Analytic Hierarchy Process 18. There are four common steps in ANP which includes
- Model construction
- Paired assessments between each two cluster or nodes
- Super matrix assessment based on outcomes from paired comparisons and
- Result investigation for the evaluation 19, 20
Proposed ANP Algorithm:
The workflow of ANP is depicted in Fig. 1.
FIG. 1: ANALYTIC NETWORK PROCESS (ANP) WORKFLOW
In a supermatrix, each element is represented at one row and one respective column. If the column sum of any column in the composed supermatrix is greater than 1, that column will be normalized. Such a supermatrix is called the super weighted matrix. The weighted supermatrix is then raised to a significantly large power in order to have the converged or stable values. The values of this limit matrix are the desired priorities of the elements with respect to goal 21.
Selection of Suitable Method for Preparation of Nanocrystal by using ANP: In this study, the ANP approach has been used to select the best method for the preparation of nanocrystals. The selection method for preparation is vital because the selected method must be feasible, and also it should give consistent results with high yield. As shown in Fig. 2, criteria, sub-criteria, and alternatives are defined, and the main criteria are method information, operational skill, viability, and technical information.
FIG. 2: THE MODEL FOR THE GOAL, SELECTING THE APT METHOD USING ANP
Criteria: Method Information: Sub-criteria under this are BCS (Biopharmaceutical classification system), Classification of drugs (BCS), Processing conditions (PC), Benefits (BE), and Expenditure.
Criteria: Operational Skill: Sub-criteria under this are Performance (PR) and Understanding (UN).
Criteria: Viability: Sub-criteria under this are Consistency (CO), Flexibility (FX), and Monotonous (MO).
Criteria: Technical Information: Sub-criteria under this are Size reduction (SR) and Processing steps (PS).
The alternatives M1 Hydrosol, M2 Sono-precipitation, M3 Spray freezing into liquid, and M4 Nanomorph® techniques are four different methods to prepare nanocrystals and are shown in Fig. 2 and Fig. 3. In Fig. 2 the model that is written to Super Decisions software can be seen. Binary comparisons have to be done after determining the criteria, sub-criteria, and alternatives. After completing binary comparisons, these data are entered into Super Decisions software which is illustrated in Fig. 4. Decision-makers have to judge each element, and the judgments are made on the basis of decision-makers' experience and knowledge. For example, when making binary comparisons, if viability is moderately more important than technical information, then assign the value 3 towards viability as shown in Fig. 4.
FIG. 3: THE RELATION BETWEEN GOAL, CRITERIA, SUB-CRITERIA AND THE ALTERNATIVES
FIG. 4: ENTERING DATA TO SUPER DECISION SOFTWARE
The Super Matrix used in this Paper is as Follows: The impact of the goal on the criteria (CRs) is represented by a vector W1. The impact of the CRs on each of the alternatives (ALTs) is denoted by a matrix W2. The inner dependence of the CRs and the inner dependence of the ALTs are represented by matrices W3 and W4. After entering the data, the results of an unweighted supermatrix, weighted supermatrix, and limit supermatrix are shown in Tables 1, 2, and 3. Finally, the selection of the best method for the preparation of nanocrystals is calculated from priorities, as shown in Fig. 5.
FIG. 5: OVERALL PRIORITY FOR THE ALTERNATIVES
RESULTS: The following results were obtained when we weigh the selection criteria and sub-criteria for the preparation of nanocrystals. The main concern of the alternatives which are the decision alternative M1 Hydrosol, M2 Sono-precipitation, M3 Spray freezing into liquid, and M4 Nanomorph® are shown in Fig. 5. Among all the methods, M2 is the best method for the preparation of nanocrystals on the basis of overall priority analysis.
The results of sensitivity analysis are shown in Fig. 6, which gives a representation of the peak criteria and sub-criteria. In Tables 1, 2, and 3 the values of the unweighted matrix, weighted matrix and limit matrix are shown, displaying the priorities of the criteria and sub-criteria through which the importance is judged.
This paper concludes that ANP evolved by Saaty is a good decision-making device, done by using a software super decision which is very easy to make the right decision and conclusion. When we select criteria and sub-criteria components, and when they are inter-related, it influences between the criteria clusters to select the right method.
With the outcome of the ANP method and Super decision software the study reveals that the Sono-precipitation method is the most suitable method for the preparation of nanocrystals since it has the highest value compared to other methods. Hence to obtain reliable and efficient decision ANP has been employed.
TABLE 1: UNWEIGHTED MATRIX
M1 | M2 | M3 | M4 | MI | OS | VI | TI | GOAL | BCS | |
M1 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.06364 |
M2 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.12191 |
M3 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.27055 |
M4 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.54390 |
MI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.54949 | 0.00000 |
OS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.24761 | 0.00000 |
VI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.12926 | 0.00000 |
TI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.07364 | 0.00000 |
GOAL | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BCS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.50829 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BE | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.26533 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
EX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.07520 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PC | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.15118 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.83333 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
UN | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.16667 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.25000 | 0.00000 | 0.00000 |
SR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.75000 | 0.00000 | 0.00000 |
CO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.63699 | 0.00000 | 0.00000 | 0.00000 |
FX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.25828 | 0.00000 | 0.00000 | 0.00000 |
MO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.10473 | 0.00000 | 0.00000 | 0.00000 |
BE | EX | PC | PR | UN | PS | SR | CO | FX | MO | |
M1 | 0.12663 | 0.52288 | 0.28763 | 0.30312 | 0.17504 | 0.51283 | 0.41173 | 0.41312 | 0.57406 | 0.42458 |
M2 | 0.16248 | 0.26256 | 0.50482 | 0.38895 | 0.40923 | 0.22609 | 0.30981 | 0.36033 | 0.12416 | 0.28198 |
M3 | 0.48745 | 0.11575 | 0.14308 | 0.12965 | 0.17504 | 0.19300 | 0.20971 | 0.10645 | 0.15089 | 0.21320 |
M4 | 0.22344 | 0.09881 | 0.06447 | 0.17829 | 0.24070 | 0.06809 | 0.06876 | 0.12011 | 0.15089 | 0.08024 |
MI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
OS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
VI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
TI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
GOAL | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BCS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BE | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
EX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PC | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
UN | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
SR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
CO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
FX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
MO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
TABLE 2: WEIGHTED MATRIX
M1 | M2 | M3 | M4 | MI | OS | VI | TI | GOAL | BCS | |
M1 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.06364 |
M2 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.12191 |
M3 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.27055 |
M4 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.54390 |
MI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.54949 | 0.00000 |
OS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.24761 | 0.00000 |
VI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.12926 | 0.00000 |
TI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.07364 | 0.00000 |
GOAL | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BCS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.50829 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BE | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.26533 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
EX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.07520 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PC | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.15118 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.83333 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
UN | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.16667 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.25000 | 0.00000 | 0.00000 |
SR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.75000 | 0.00000 | 0.00000 |
CO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.63699 | 0.00000 | 0.00000 | 0.00000 |
FX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.25828 | 0.00000 | 0.00000 | 0.00000 |
MO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.10473 | 0.00000 | 0.00000 | 0.00000 |
BE | EX | PC | PR | UN | PS | SR | CO | FX | MO | |
M1 | 0.12663 | 0.52288 | 0.28763 | 0.30312 | 0.17504 | 0.51283 | 0.41173 | 0.41312 | 0.57406 | 0.42458 |
M2 | 0.16248 | 0.26256 | 0.50482 | 0.38895 | 0.40923 | 0.22609 | 0.30981 | 0.36033 | 0.12416 | 0.28198 |
M3 | 0.48745 | 0.11575 | 0.14308 | 0.12965 | 0.17504 | 0.19300 | 0.20971 | 0.10645 | 0.15089 | 0.21320 |
M4 | 0.22344 | 0.09881 | 0.06447 | 0.17829 | 0.24070 | 0.06809 | 0.06876 | 0.12011 | 0.15089 | 0.08024 |
MI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
OS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
VI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
TI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
GOAL | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BCS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BE | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
EX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PC | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
UN | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
SR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
CO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
FX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
MO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
TABLE 3: LIMIT MATRIX
M1 | M2 | M3 | M4 | MI | OS | VI | TI | GOAL | BCS | |
M1 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.07437 | 0.14089 | 0.22794 | 0.21850 | 0.08087 | 0.06364 |
M2 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.10057 | 0.19616 | 0.14556 | 0.14444 | 0.08886 | 0.12191 |
M3 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.14860 | 0.06861 | 0.06455 | 0.10276 | 0.07637 | 0.27055 |
M4 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.17646 | 0.09435 | 0.06194 | 0.03429 | 0.08724 | 0.54390 |
MI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.18316 | 0.00000 |
OS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.08254 | 0.00000 |
VI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.04308 | 0.00000 |
TI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.02455 | 0.00000 |
GOAL | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BCS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.25414 | 0.00000 | 0.00000 | 0.00000 | 0.09310 | 0.00000 |
BE | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.13267 | 0.00000 | 0.00000 | 0.00000 | 0.04860 | 0.00000 |
EX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.03760 | 0.00000 | 0.00000 | 0.00000 | 0.01377 | 0.00000 |
PC | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.07559 | 0.00000 | 0.00000 | 0.00000 | 0.02769 | 0.00000 |
PR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.41667 | 0.00000 | 0.00000 | 0.06878 | 0.00000 |
UN | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.08333 | 0.00000 | 0.00000 | 0.01376 | 0.00000 |
PS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.12500 | 0.00614 | 0.00000 |
SR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.37500 | 0.01841 | 0.00000 |
CO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.31849 | 0.00000 | 0.02745 | 0.00000 |
FX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.12914 | 0.00000 | 0.01113 | 0.00000 |
MO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.05237 | 0.00000 | 0.00451 | 0.00000 |
BE | EX | PC | PR | UN | PS | SR | CO | FX | MO | |
M1 | 0.12663 | 0.52288 | 0.28763 | 0.30312 | 0.17504 | 0.51283 | 0.41173 | 0.41312 | 0.57406 | 0.42458 |
M2 | 0.16248 | 0.26256 | 0.50482 | 0.38895 | 0.40923 | 0.22609 | 0.30981 | 0.36033 | 0.12416 | 0.28198 |
M3 | 0.48745 | 0.11575 | 0.14308 | 0.12965 | 0.17504 | 0.19300 | 0.20971 | 0.10645 | 0.15089 | 0.21320 |
M4 | 0.22344 | 0.09881 | 0.06447 | 0.17829 | 0.24070 | 0.06809 | 0.06876 | 0.12011 | 0.15089 | 0.08024 |
MI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
OS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
VI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
TI | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
GOAL | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BCS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
BE | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
EX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PC | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
UN | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
PS | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
SR | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
CO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
FX | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
MO | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 | 0.00000 |
FIG. 6: SENSITIVITY ANALYSIS
DISCUSSION: This paper concludes that ANP evolved by Saaty is a good decision-making device, done by using a software super decision which is very easy to make the right decision and conclusion. When we select criteria and sub-criteria components, and when they are inter-related, it influences between the criteria clusters to select the right method.
CONCLUSION: This paper aims to present a systematic approach for selecting the best method for the preparation of nanocrystals by implementing one of the most effective decision-making tools that is ANP. ANP is very helpful in selecting the best method based on the criteria and sub-criteria aspects of a decision. As per saaty, the alternative with the highest priority will be chosen as best alternative. With the outcome of ANP method and super decision software, the study reveals that the Sonoprecipitation method is the most suitable method for the preparation of nanocrystals since it has the highest value compared to other methods. Hence to obtain reliable and efficient decision ANP has been employed.
ACKNOWLEDGEMENT: The writer is grateful to Dr. Muthukumar, Assistant Professor, Department of Pharmacy, Annamalai University, for offering the required equipment, support, and guidance during the work.
CONFLICTS OF INTEREST: Authors express no conflict of interest.
REFERENCES:
- Keck CM and Muller RH: Drug Nanocrystals of poorly soluble Drug products by High Pressure Homogenisation. Eur J Pharm and Biopharm 2006; 62: 3-16.
- Abu-Izza KA, Garcia-Contreras L and Lu DR: Preparation and evaluation of zidovudine-loaded sustained-release microspheres: optimization of multiple response variables. J Pharm Sci 1996; 85: 572-76.
- Abu-Izza KA, Garcia-Contreras L and Lu DR: Preparation and evaluation of sustained-release AZT-loaded micro-spheres: optimization of the release characteristics using response surface methodology. J Pha Sci 1996; 85: 144-49.
- Swamivelmanickam M, Muralidharan C, Manavalan R, Venkatesen P and Valliappan K: Selection of best method for the formulation of orodispersible tablets by applying fuzzy analytic hierarchy process. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2011; 2(1): 525-40.
- Velmurugan R, Selvamuthukumar S and Manavalan R: Multi criteria decision making to select the suitable method for the preparation of nanoparticles using an analytical hierarchy process. Pharm 2011; 66(11): 836-42.
- Banker GS and Rhodes CT: Modern pharmaceutics. New York: Marcel Dekker 2004.
- Gohel MC and Amin AF: Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Control Release 1998; 51: 115-22.
- Jain SK, Awasthi AM, Jain N and Agrawal GP: Calcium silicate-based microspheres of repaglinide for gastro-retentive floating drug delivery: preparation and in-vitro characterization. J Control Release 2005; 107: 300-09.
- Velmurugan R and Selvamuthukumar S: The analytic network process for the pharmaceutical sector: Multi criteria decision making to select the suitable method for the preparation of nanoparticles. DARU Journal of Pharmaceutical Sciences 2012; 20: 59.
- Junghanns JUAH and Muller RH: Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008; 3(3): 295-309.
- Müller RH and Keck CM: Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles J Biotechnol. 2004; 113: 151-70.
- Lee J, Choi JY and Park CH: Characteristics of polymers enabling nanocomminution of water-insoluble drugs. Int J Pharm 2008; 355: 328-36.
- Mitali K, Ranjita S, Nanda GS, Sven G, Lin Li and Muller RH: Long-term stability of quercetin nanocrystals prepared by different methods. Journal of Pharmacy and Pharmacology 2012; 64(10): 1394-402.
- Whitney WR and Noyes AA: The rate of solution of solid substances in their own solutions. Journal of the American Chemical Society 1897; 19(12): 930-34.
- Ponchel G and Duchene D: Bioadhesion of solid oral dosage forms, why and how? European Journal of Pharmaceutics and Biopharmaceutics 1997; 44(1): 15-23.
- Tzu-Lan C, Honglei Z, Danni L and Jun F: Nanocrystal technology for drug formulation and delivery. Front Chem Sci Eng 2015; 9(1): 1-14.
- Ebru Y and Korkut UA. Application of analytic network process: weighting of selection criteria for civil pilots. Journal of Aeronautics and Space Technologies 2011; 2(5): 1-2.
- Promentilla MAB, Furuichi T, Ishii K and Tanikawa N: Evaluation of remedial counter measures using the analytic network process. Waste Manag 2006; 26: 1410-21.
- Saaty T: Decision Making with Dependence and Feedback: Analytic Network Process. Pittsburgh: RWS Publications 2011.
- Saaty T: Theory and applications of the analytic network process, decision making with benefits, opportunities, costs and risks. Pittsburgh: RWS Publications 2005.
- Saaty T: Rank from comparisons and from ratings in the analytic hierarchy/ network processes. Eur J Oper Res 2006; 168: 557-70.
How to cite this article:
Kyavars V: Application of analytic network process: weighting of selection criteria to select the suitable method for the preparation of nanocrystals. Int J Pharm Sci & Res 2021; 12(7): 3925-32. doi: 10.13040/IJPSR.0975-8232.12(7).3925-32.
All © 2013 are reserved by the International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.